These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2166159)

  • 1. Lymphoproliferative responses in recrudescent orofacial herpetic infections.
    Vestey JP; Norval M; Howie SE
    J R Soc Med; 1990 May; 83(5):308-11. PubMed ID: 2166159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
    McKenna DB; Neill WA; Norval M
    Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
    Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
    Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
    Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.
    Thong YH; Vincent MM; Hensen SA; Fuccillo DA; Rola-Pleszczynski M; Bellanti JA
    Infect Immun; 1975 Jul; 12(1):76-80. PubMed ID: 166930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe eczema herpeticum is associated with prolonged depression of cell-mediated immunity to herpes simplex virus.
    Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
    Curr Probl Dermatol; 1989; 18():158-61. PubMed ID: 2545414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study between viral isolation and indirect immunofluorescence in the diagnosis of herpes simplex virus.
    Galadari I; Fowzan AW
    Eur Ann Allergy Clin Immunol; 2006 Feb; 38(2):62-4. PubMed ID: 16711539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.
    Shillitoe EJ; Wilton JM; Lehner T
    Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of UV therapy on immune function in patients with psoriasis.
    Gilmour JW; Vestey JP; Norval M
    Br J Dermatol; 1993 Jul; 129(1):28-38. PubMed ID: 8396409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative and serological responses to herpes simplex virus during primary infection, recrudescence, and re-infection in a murine model.
    Maingay JP; Howie SE; Norval M; Moodycliffe AM; Neill WA
    Viral Immunol; 1989; 2(2):115-26. PubMed ID: 2789063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of a herpes simplex subunit vaccine.
    Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
    J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to herpes simplex virus type 1 polypeptides and glycoproteins in primary and recurrent infection.
    Mann DR; Hilty MD
    Pediatr Res; 1982 Mar; 16(3):176-80. PubMed ID: 6278389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herpes simplex. Oral and peroral infection with Herpes simplex virus].
    Maeglin B
    Schweiz Monatsschr Zahnmed; 1987; 97(12):1532-6. PubMed ID: 2829351
    [No Abstract]   [Full Text] [Related]  

  • 18. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.
    Kahlon J; Lakeman FD; Ackermann M; Whitley RJ
    J Clin Microbiol; 1986 Apr; 23(4):725-30. PubMed ID: 2422204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune characteristics correlating with HSV-1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes.
    McTavish H; Zerebiec KW; Zeller JC; Shekels LL; Matson MA; Kren BT
    Immun Inflamm Dis; 2019 Mar; 7(1):22-40. PubMed ID: 30756512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of recurrent oral herpes simplex virus infection.
    Glick M
    Compend Contin Educ Dent; 2002 Jul; 23(7 Suppl 2):4-8. PubMed ID: 12789980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.